SYMBRAVO Trademark

Trademark Overview

On Friday, January 22, 2021, a trademark application was filed for SYMBRAVO with the United States Patent and Trademark Office. The USPTO has given the SYMBRAVO trademark a serial number of 90482774. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, June 13, 2024. This trademark is owned by Axsome Therapeutics, Inc.. The SYMBRAVO trademark is filed in the Pharmaceutical Products category with the following description:

Prescription medicines for the treatment of migraines
symbravo

General Information

Serial Number90482774
Word MarkSYMBRAVO
Filing DateFriday, January 22, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 10, 2021

Trademark Statements

Goods and ServicesPrescription medicines for the treatment of migraines
Pseudo MarkSYM BRAVO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code005
First Use Anywhere DateSaturday, January 1, 2022
First Use In Commerce DateWednesday, May 1, 2024

Trademark Owner History

Party NameAxsome Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10007
Party NameAxsome Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10038

Trademark Events

Event DateEvent Description
Tuesday, January 26, 2021NEW APPLICATION ENTERED
Friday, April 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 24, 2021ASSIGNED TO EXAMINER
Thursday, July 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 10, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 10, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 12, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, January 12, 2022SOU EXTENSION 1 FILED
Wednesday, January 12, 2022SOU EXTENSION 1 GRANTED
Friday, January 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 30, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 30, 2022SOU EXTENSION 2 FILED
Thursday, June 30, 2022SOU EXTENSION 2 GRANTED
Saturday, July 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, March 30, 2023SOU EXTENSION 3 FILED
Thursday, March 30, 2023SOU EXTENSION 3 GRANTED
Saturday, April 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 10, 2023SOU EXTENSION 4 FILED
Monday, July 10, 2023SOU EXTENSION 4 GRANTED
Wednesday, July 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 6, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 6, 2024SOU EXTENSION 5 FILED
Friday, February 23, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 23, 2024SOU EXTENSION 5 GRANTED
Saturday, February 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 15, 2024USE AMENDMENT FILED
Wednesday, May 15, 2024TEAS STATEMENT OF USE RECEIVED
Friday, May 24, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, June 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 13, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

symbravo migraines treatment medicines prescription